Incubation of nerve endings with a physiological concentration of Abeta1-42 activates CaV2.2(N-Type)-voltage operated calcium channels and acutely increases glutamate and noradrenaline release

J Alzheimers Dis. 2004 Jun;6(3):243-55. doi: 10.3233/jad-2004-6305.

Abstract

We wish to understand the normal function of amyloid-beta peptides (Abeta) and to see if they destabilize neuronal calcium homeostasis [Mattson et al., J. Neurosci. 12 (1992), 376-389]. We observed that a physiological concentration (10 nM) of Abeta1-42 increased both glutamate and noradrenaline exocytosis from rat cortical nerve endings at least in part by activation of N-type Ca2+ channels. Abeta oligomers rather than monomers or fibrils probably are the most active form. Three alternatively-proposed effects of Abeta (reactive oxygen species formation, membrane perforation, and disruption of Ca2+ stores) also were tested by incubating nerve endings with a relatively high (by this study's standards) concentration of Abeta1-42(100 nM). None of the three proposed effects were detected during these incubations. These results support the hypothesis that persistent elevations of Abeta, which normally operates as a modulator of N-type voltage gated calcium channels, could increase internal nerve ending Ca2+ and excitatory neurotransmitter release to produce the early neurotoxic effects that eventually lead to Alzheimer's disease.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alzheimer Disease / chemically induced*
  • Alzheimer Disease / pathology
  • Amyloid beta-Peptides / administration & dosage
  • Amyloid beta-Peptides / analysis
  • Amyloid beta-Peptides / pharmacology*
  • Amyloid beta-Peptides / toxicity*
  • Animals
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / pathology
  • Female
  • Glutamic Acid / metabolism
  • Hippocampus / drug effects
  • Hippocampus / pathology
  • Male
  • Nerve Degeneration / pathology*
  • Nerve Endings / drug effects*
  • Nerve Endings / pathology*
  • Nerve Tissue Proteins / metabolism
  • Norepinephrine / metabolism
  • Peptide Fragments / metabolism
  • Peptide Fragments / pharmacology*
  • Plaque, Amyloid / metabolism
  • Rats
  • Rats, Long-Evans
  • Rats, Sprague-Dawley
  • Rats, Wistar
  • Reactive Oxygen Species / metabolism

Substances

  • Amyloid beta-Peptides
  • Nerve Tissue Proteins
  • Peptide Fragments
  • Reactive Oxygen Species
  • amyloid beta-protein (1-40)
  • amyloid beta-protein (1-42)
  • Glutamic Acid
  • Norepinephrine